TiumBio Co., Ltd. (KOSDAQ:321550)
South Korea · Delayed Price · Currency is KRW 6,230.00
0.00 (0.00%)
At close: Feb 19, 2026
TiumBio Market Cap
TiumBio has a market cap or net worth of 178.83 billion as of February 20, 2026. Its market cap has increased by 68.29% in one year.
Market Cap
178.83B
Enterprise Value
181.82B
Revenue
9.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,230.00
Market Cap Chart
Since November 22, 2019, TiumBio's market cap has decreased from 311.90B to 178.83B, a decrease of -42.66%. That is a compound annual growth rate of -8.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 181.16B | 6.20% |
| Dec 30, 2025 | 170.58B | 51.78% |
| Dec 30, 2024 | 112.39B | -53.28% |
| Dec 28, 2023 | 240.56B | -20.51% |
| Dec 29, 2022 | 302.63B | -34.44% |
| Dec 30, 2021 | 461.60B | -7.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ISU Abxis | 226.00B |
| Vaxcell-Bio Therapeutics | 220.71B |
| Prestige Biologics | 219.65B |
| Bio Solution | 214.17B |
| QuadMedicine | 208.23B |
| Kangstem Biotech | 206.45B |
| Ensol Biosciences | 201.99B |
| CORESTEMCHEMON | 165.91B |